| Literature DB >> 33428118 |
Ioana Popovici1, Manuel J Carvajal2, Patti Peeples3, Silvia E Rabionet1,4.
Abstract
OBJECTIVE: The aim was to estimate the wage-and-salary earnings of a sample of health economics, outcomes research, and market access (HE/OR/MA) professionals; compare male versus female and US versus non-US earnings; assess the magnitude of the effect of several human-capital and job-related covariates on the determination of earnings; and examine inequality in the distribution of earnings.Entities:
Year: 2021 PMID: 33428118 PMCID: PMC7797494 DOI: 10.1007/s41669-020-00247-2
Source DB: PubMed Journal: Pharmacoecon Open ISSN: 2509-4262
Number of observations in the sample and estimated values of the mean and standard deviation of HE/OR/MA professionals’ annual wage-and-salary earnings (in US dollars) by gender and location, 2017
| Location | Indicator | Gender | ||
|---|---|---|---|---|
| Men | Women | Both genders | ||
US ( | Number of observations Mean ($) Standard deviation ($) | 120 181,917 108,725 | 112 163,415 66,521 | 232 172,985 91,114 |
Non-US ( | Number of observations Mean ($) Standard deviation ($) | 75 103,900 73,037 | 65 91,885 55,534 | 140 98,321 65,544 |
| Both locations | Number of observations Mean ($) Standard deviation ($) | 195 151,910 103,604 | 177 137,147 71,470 | 372 144,886 89,947 |
Mean income differences between genders: F = 2.99 (p = 0.084)
Mean income differences between locations: F = 71.88 (p ≤ 0.001)
Gender–location interaction effect: F = 0.14 (not statistically significant)
Estimated sample values of variables hypothesized to influence HE/OR/MA professionals’ annual wage-and-salary earnings by gender and location, 2017
| Variable | Location | Variable categories | Gender | ||
|---|---|---|---|---|---|
| Men | Women | Both genders | |||
| Age (years), mean (standard deviation) | US ( | 42.9 (10.6) | 41.9 (10.3) | 42.4 (10.4) | |
| Non-US ( | 39.7 (10.6) | 39.2 (9.2) | 39.4 (9.9) | ||
| Both locations | 41.6 (10.7) | 40.9 (9.9) | 41.3 (10.3) | ||
| Highest academic degree attained (%) | US ( | Baccalaureate Master’s Doctoral Other | 11.0 39.0 50.0 – | 8.1 40.5 50.5 0.9 | 9.6 39.8 50.2 0.4 |
| Non-US ( | Baccalaureate Master’s Doctoral Other | 6.9 51.4 38.9 2.8 | 14.3 50.8 33.3 1.6 | 10.4 51.0 36.4 2.2 | |
| Both locations | Baccalaureate Master’s Doctoral Other | 9.5 43.7 45.7 1.1 | 10.3 44.2 44.3 1.2 | 9.9 44.0 45.0 1.1 | |
| Employment status (%) | US ( | Full time Part time | 98.3 1.7 | 93.7 6.3 | 96.1 3.9 |
| Non-US ( | Full time Part time | 100.0 – | 98.5 1.5 | 99.3 0.7 | |
| Both locations | Full time Part time | 99.0 1.0 | 95.4 4.6 | 97.3 2.7 | |
| Type of work (%) | US ( | Health economics and outcomes research Market value or market access Technical operations Academia Other | 46.7 36.6 10.0 4.2 2.5 | 43.7 30.4 17.8 4.5 3.6 | 45.3 33.6 13.8 4.3 3.0 |
| Non-US ( | Health economics and outcomes research Market value or market access Technical operations Academia Other | 36.0 52.0 6.7 1.3 4.0 | 40.0 44.6 7.7 3.1 4.6 | 37.9 48.6 7.1 2.1 4.3 | |
| Both locations | Health economics and outcomes research Market value or market access Technical operations Academia Other | 42.6 42.6 8.6 3.1 3.1 | 42.3 35.6 14.1 4.0 4.0 | 42.5 39.2 11.3 3.5 3.5 | |
| Primary job level (%) | US ( | Top executive Director Associate or assistant director Manager Analyst Faculty member Other | 25.0 33.3 8.3 11.7 8.3 5.0 8.4 | 16.0 29.5 15.2 15.2 8.0 2.7 13.4 | 20.7 31.5 11.6 13.4 8.2 3.9 10.7 |
| Non-US ( | Top executive Director Associate or assistant director Manager Analyst Faculty member Other | 14.7 33.3 4.0 28.0 16.0 1.3 2.7 | 4.6 24.6 9.3 33.8 20.0 1.5 6.2 | 10.0 29.3 6.4 30.7 17.9 1.4 4.3 | |
| Both locations | Top executive Director Associate or assistant director Manager Analyst Faculty member Other | 21.0 33.3 6.7 17.9 11.3 3.6 6.2 | 11.9 27.7 13.0 22.0 12.4 2.3 10.7 | 16.6 30.6 9.7 19.9 11.8 3.0 8.4 | |
| Employer’s main area of operations (%) | US ( | Pharmaceutical or biotechnology Contract research or consulting Academia Medical device Managed care Other | 40.0 27.5 5.8 10.8 10.0 5.9 | 44.6 24.1 5.4 8.0 7.1 10.8 | 42.2 25.9 5.6 9.5 8.6 8.2 |
| Non-US ( | Pharmaceutical or biotechnology Contract research or consulting Academia Medical device Managed care Other | 52.0 26.6 1.3 5.3 1.3 13.5 | 56.9 24.7 3.1 7.7 - 7.6 | 54.3 25.7 2.1 6.4 0.7 10.8 | |
| Both locations | Pharmaceutical or biotechnology Contract research or consulting Academia Medical device Managed care Other | 44.6 27.2 4.1 8.7 6.7 8.7 | 49.2 24.3 4.5 7.9 4.5 9.6 | 46.8 25.8 4.3 8.3 5.7 9.1 | |
HE/OR/MA health economics, outcomes research, and market access
Estimated least-squares coefficients, their standard errors (in parentheses), and (two-tail) levels of significance of covariates in the model by gender and location, 2017
| Variable | Term | Estimated least-squares coefficients, standard errors, and levels of significance | |||
|---|---|---|---|---|---|
| Living in the USA ( | Living outside the USA ( | ||||
| Men ( | Women ( | Men ( | Women ( | ||
Constant Age (linear) Age (quadratic) Doctoral degree HE/OR specialist Top executive or director Pharmaceutical or biotechnology firm | 8.9861 0.1134* (0.0241) − 0.0012* (0.0003) 0.0324 (0.0786) − 0.0395 (0.0784) 0.4907* (0.0830) 0.2624* (0.0745) | 9.9857 0.0590‡ (0.0259) − 0.0005† (0.0003) 0.2228* (0.0673) − 0.0296 (0.0668) 0.4260* (0.0699) 0.2401* (0.0656) | 8.8019 0.0907‡ (0.0393) − 0.0009† (0.0005) 0.0540 (0.1145) − 0.4090* (0.1300) 0.6036* (0.1322) 0.3787* (0.1139) | 7.4529 0.1422* (0.0476) − 0.0014‡ (0.0006) 0.0418 (0.1273) 0.2458† (0.1372) 0.6169* (0.1382) 0.4049* (0.1306) | |
Adjusted | 19.03* 0.485 | 22.44* 0.541 | 24.63* 0.666 | 15.57* 0.585 | |
HE health economics, OR outcomes research
*Statistically significant (p ≤ 0.01)
‡Statistically significant (p ≤ 0.05)
†Statistically significant (p ≤ 0.10)
Estimated sample values of three measures of dispersion of HE/OR/MA professionals’ annual wage-and-salary earnings by gender and location, 2017
| Measure of dispersion | Location | Gender | ||
|---|---|---|---|---|
| Men | Women | Both genders | ||
| Lower median share | US | 0.314 | 0.337 | 0.324 |
| Non-US | 0.212 | 0.250 | 0.235 | |
| Both locations | 0.267 | 0.288 | 0.278 | |
| 90–10 decile ratio | US | 7.45 | 4.93 | 6.31 |
| Non-US | 10.20 | 8.07 | 9.31 | |
| Both locations | 13.96 | 11.02 | 12.53 | |
| Gini coefficient | US | 0.273 | 0.228 | 0.254 |
| Non-US | 0.385 | 0.334 | 0.365 | |
| Both locations | 0.334 | 0.293 | 0.317 | |
HE/OR/MA health economics, outcomes research, and market access
| There appear to be disparities between the earnings of health economics, outcomes research, and market access professionals living in the USA compared to other countries; within each location, there are mild gender disparities. |
| There also appears to be greater earnings inequality outside the USA than within the USA. |
| Within each location, there may be more unequal distribution of men’s earnings compared to women’s earnings. |